TREA

97368281 - ALDYSTRO

Follow

Information

  • Trademark
  • 97368281
  • Serial Number
    97368281
  • Filing Date
    April 18, 2022
    2 years ago
  • Transaction Date
    April 27, 2024
    a month ago
  • Status Date
    April 17, 2024
    a month ago
  • Published for Opposition Date
    March 14, 2023
    a year ago
  • Location Date
    May 09, 2023
    a year ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    LORENZO, GEORGE M
  • Attorney Name
    Maury M. Tepper, III
    Law Office Assigned Location Code
    L10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ALDYSTRO
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
Case File Event Statements
  • 4/21/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/25/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/3/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/8/2023 - a year ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/22/2023 - a year ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/14/2023 - a year ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/14/2023 - a year ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/9/2023 - a year ago
    8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 10/27/2023 - 7 months ago
    9 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/27/2023 - 7 months ago
    10 - SOU EXTENSION 1 FILED Type: EXT1
  • 10/27/2023 - 7 months ago
    11 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 10/31/2023 - 7 months ago
    12 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/17/2024 - a month ago
    13 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/17/2024 - a month ago
    14 - SOU EXTENSION 2 FILED Type: EXT2
  • 4/17/2024 - a month ago
    15 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 4/18/2024 - a month ago
    16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA